IKK INHIBITORS

The present invention relates to IKK-alpha inhibitory compounds, or a pharmaceutically acceptable salts, hydrates or solvates thereof, having the structural Formula (I), shown below: (I) wherein R1, X, R3 R4 and X1 are each as defined herein. The present invention also relates to processes for the p...

Full description

Saved in:
Bibliographic Details
Main Authors BERRETTA, Giacomo, MASCI, Domiziana, BREEN, David, SUCKLING, Colin J, ALSFOUK, Aisha A, LLONA-MINGUEZ, Sabin, RILEY, Christopher, BAIGET, Jessica, LAWSON, Christopher, ANTHONY, Nahoum G, WEST, Christopher, AMMAR, Usama, HUGGAN, Judith, MACKAY, Simon P
Format Patent
LanguageEnglish
French
Published 16.11.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to IKK-alpha inhibitory compounds, or a pharmaceutically acceptable salts, hydrates or solvates thereof, having the structural Formula (I), shown below: (I) wherein R1, X, R3 R4 and X1 are each as defined herein. The present invention also relates to processes for the preparation of these compounds, to pharmaceutical compositions comprising them, and to their use in the treatment of proliferative disorders, such as cancer, as well as other diseases or conditions in which IKK-alpha activity is implicated. La présente invention concerne des composés inhibiteurs d'IKK-alpha ou des sels, hydrates ou solvates pharmaceutiquement acceptables de ceux-ci, ayant la formule structurale (I), représentée ci-dessous : (I) dans laquelle R1, X, R 3 R 4 et X 1 sont chacun tels que définis dans la description. La présente invention concerne également des procédés de préparation de ces composés, des compositions pharmaceutiques les comprenant, et leur utilisation dans le traitement de troubles prolifératifs, tels que le cancer, ainsi que d'autres maladies ou affections dans lesquelles l'activité d'IKK-alpha est impliquée.
Bibliography:Application Number: WO2023GB51242